Alzamend Neuro presents Phase 1/2A 7T lithium imaging results showing trends favoring AL001

Alzamend Neuro presented Phase 1/2A 7T brain pharmacokinetic imaging data showing trends toward higher brain lithium levels and AUC for AL001 versus lithium carbonate.Key Highlights:Original SEC Filing: Alzamend Neuro, Inc. [ ALZN ] - 8-K - Sep. 29, 2026This is an AI-powered summary. It may contain…